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Available online 16 February 2016Recent advances in membrane contact site (MCS) biology have revealed key roles for MCSs in inter-organellar
exchange, the importance of which is becoming increasingly apparent. Roles for MCSs in many essential physiological
processes including lipid transfer, calcium exchange, receptor tyrosine kinase signalling, lipid droplet formation,
autophagosome formation, organelle dynamics and neurite outgrowth have been reported. The ER forms an extensive
and dynamic network of MCSs with a diverse range of functionally distinct organelles. MCSs between the ER and
endocytic pathway are particularly abundant, suggesting important physiological roles. Here, our current knowledge
of the formation and function of ER contact sites with endocytic organelles from studies in mammalian systems is
reviewed. Their relatively poorly deﬁned molecular composition and recently identiﬁed functions are discussed. In
addition, likely, but yet to be established, roles for these contacts in lipid transfer and calcium signalling are considered.
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Membrane contact sites (MCSs) are regions of close apposition
(≤30 nm) between two organelles, establishing microdomains for
interorganellar exchange. The ER network forms extensive MCSs with
multiple organelles within the cell, including the plasma membrane,
mitochondria and Golgi apparatus. The ﬁrst indication that the ER
might make functional contact sites with endocytic organelles came
from studies in yeast that identiﬁed a junction between the nucleus
and vacuole formed by direct interaction between the ER protein Nvj1
and the vacuole protein Vac8 [1]. Although extremely abundant, ER
contacts with the endocytic pathway (Fig. 1) in mammalian cells were
only recently described [2,3]. Membrane contact sites are stabilized
by tethering complexes that maintain close proximity between the ap-
posing membranes without membrane fusion. These tethers can often
be discerned by electron microscopy, as multiple strands between the
apposing membranes of the two organelles (Fig. 1). While our under-
standing of the composition of tethering complexes remains incom-
plete, with recent advances in membrane contact site biology, many
organelle-speciﬁc tethering proteins have been identiﬁed [4–6]. The
ER-localized Vesicle associated membrane protein (VAMP)-Associated
Proteins (VAPs) have been implicated in tethering numerous different
MCSs. For example, ER:mitochondrial MCSs are promoted by
VAPB:PTPIP51 interaction [7],while ER:Golgi MCSs are promoted by
VAP interaction with OSBP, CERT and Nir2 FFAT (diphenylalanine in
an acidic tract) motifs [8]. A VAP homologue in yeast (Scs2) has beencape edited by
access article underimplicated in MCSs between the ER and the plasma membrane that
are important in the regulation of phosphoinositide lipid turnover [9].
Moreover, VAP interaction with the FFAT motifs of the sterol binding
proteins ORP1L [3] and STARD3 [10] on late endosomes/lysosomes
have been implicated in MCS formation between the ER and the
endocytic pathway, as will be discussed in more detail below.2. ER-endosome contact site formation
The regulation andmolecular composition of ER-endocytic organelle
MCSs remains poorly characterized, but three independent studies im-
plicate VAPs in tethering these contacts (Fig. 2), either by direct interac-
tion with the FFAT motifs of endosomal sterol-binding proteins ORP1L
and STARD3, or indirectly, by interaction with another integral ER
membrane protein, protrudin, which interacts with Rab7 and phos-
phatidylinositol 3-phosphate (PI3P) at the endosome [11].
ORP1L is a sterol and oxysterol binding protein [12] that is recruited
to a population of endosomes that are positive for the Neimann-Pick
type C (NPC) protein NPC113 by interaction with Rab7 [14]. Under con-
ditions of low cholesterol in the endocytic pathway, ORP1L undergoes a
conformational change that promotes VAP interaction [3]. Overexpres-
sion of an ORP1L mutant (ΔORD) in which the c-terminal oxysterol-
binding domain had been removed to mimic ORP1L conformation
under cholesterol-free conditions (thereby favouring VAP interaction)
increased both the number and size of ER-endosome contact sites [3].
Similarly, over-expression of STARD3 or STARD3NL, which localize to
a different population of earlier endosomes that contain the cholesterol
transporter ABCA3 [13], resulted in a striking extension of ER-endosome
contacts [10]. These data signal a role for VAP interactions withthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. Electron micrograph of an ER-endosome membrane contact site. Hela cells were
prepared for transmission electron microscopy. The image shows membrane contact
sites (black arrows) between the ER and an endosome. Tethers (white arrowheads)
between the two organelles are often visible at the contact site. Scale bar, 200 nm.
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sites, but it should be noted that while the increase in contact sites me-
diated by STARD3 overexpression was VAP-dependent, neither study
reported a reduction in basal contact site formation on depletion of
VAP/ORP1L/STARD3. It is therefore possible that VAP interactions
might function at and/or stabilize existing ER-endosome contacts rather
than initiating contact site formation.
As mentioned above, in addition to the interactions with endosomal
FFAT-motif-containing proteins, VAPA also binds the FFAT motif of an
integral ER membrane protein, protrudin [11]. Protrudin also contains
a PI3P-interacting FYVE domain and a low complexity region through
which it interacts with Rab7. Coincident interaction of ER-localized
protrudin with endosomal PI3P and RAB7 promotes the formation of
ER-endosome contact sites and the recruitment of VAPA to the contact
[11]. Overexpression of protrudin results in rearrangement of the ER
to form multiple and extended contacts, demonstrating a role inFig. 2. VAP interactions with FFAT motif-containing proteins at ER-endosome contact sites. VAP
RILP/dynein-mediatedminus-end directed transport towards the perinuclear compartment. VA
promoting contact site formation. VAP additionally binds the FFAT motif of an ER-anchored pr
dependent, plus-end directed, transport towards the periphery of the cell.recruiting the ER to the contact site, but whether protrudin stabilizes
pre-existing contacts or initiates contact site formation remains unclear.
Another interaction reported to stabilize ER-endosome contact sites
is that between the ER localized protein tyrosine phosphatase 1B
(PTP1B) with endocytosed EGFR (Fig. 3). Depletion of PTP1B reduced
contact sites and EGF stimulation increased the size of contacts, but
these contact sites still formed in the absence of PTP1B or EGF [2], sug-
gesting that existing contact sites provide platforms for PTP1B-EGFR in-
teractions, which stabilize what would otherwise be extremely
transient sites of contact. As yet there is no evidence for recruitment
of VAPs to these contact sites, but as key regulators are identiﬁed, a
role for VAPs might also become apparent.
Interestingly, in addition to binding Rab7, ORP1L, like protrudin, also
binds phosphoinositides, through its PH domain [14], but the signiﬁ-
cance of this in its role at contact sites has not been established. Rab7 in-
teractions are required for both protrudin- and ORP1L-regulated ER-
endosome contact sites, suggesting a central role for this small GTPase
in the regulation of ER-endosome contact sites. A Rab exchange from
Rab5 to Rab7 marks the maturation of an early, sorting endosome, to a
late endosome [15]. That PTP1B-EGFR interactions occur at early
(Rab5-positive) as well as mature (Rab7-positive) endosomes, suggests
that the regulation of ER-endosomes MCSs might involve several key
tethering complexes speciﬁc to different endosome populations, possi-
bly deﬁned by the Rab5–Rab7 switch.3. Functions of ER-endosome contact sites
3.1. Endosome ﬁssion and positioning
Endocytic organelles are extremely dynamic, continuously moving
as they progress from initial endocytosed vesicles at the plasma mem-
brane to sites of fusion with the predominantly perinuclear lysosomal
compartment. However, not all cargo is destined for lysosomal degrada-
tion and many sorting, fusion and ﬁssion events occur along the path-
way mediating alternative fates, notably recycling to the plasma
membrane or retrograde transport to the trans-Golgi network [16].interacts with the FFAT motif of ORP1L when LDL-cholesterol is low, terminating ORP1L/
P also interacts with the FFATmotif of STARD3, another endosomal sterol-binding protein,
otein, protrudin, which, through coincident binding of Rab7 and PI3P, mediates kinesin1-
Fig. 3. PTP1B interactions at ER-endosome contact sites. PTP1B dephosphorylates both endocytosed EGFR and HRS, promoting ILV formation and downregulation of EGFR tyrosine kinase
activity. PTP1B also dephosphorylates both G-CSFR and Prdx4.
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and timing for ﬁssion events thatmediate the budding awayof a tubular
Rab4-positive transferrin-containing compartment to be recycled to the
cell surface from a vacuolar Rab5-positive EGFR-containing early endo-
some that is destined for lysosomal fusion [17]. Sorting events continue
to occur on late, Rab7-positive endosomes, with the retromer complex
sorting cargo into specialized domains for retrograde transport to the
Golgi [18]. FAM21 localizes to these sorting domains and ER tubules
were found to make endosome contact sites at FAM21-positive sorting
domains immediately prior to ﬁssion. EGF is again retained in the vacu-
olar, Rab7-positive compartment, while a smaller compartment, also
positive for Rab7, buds away [17].
Endosomes destined for lysosomal fusion are trafﬁcked along the cy-
toskeleton as they undergo sorting, fusion and ﬁssion events [19] and
ER-endosome contact sites are important in controlling the association
of endosomes with the cytoskeleton. ORP1L forms a complex at late
endosomeswith Rab7 and the Rab7 effector RILP. The p150Glued subunit
of the dynein/dynactin microtubule motor complex directly binds RILP,
mediating minus-end-directed transport towards the nucleus. RILP ad-
ditionally binds the homotypic fusion and vacuole protein sorting
(HOPS) complex, mediating endosome tethering for fusion events
[20]. Under conditions of low cholesterol in the endocytic pathway,
ORP1L–VAPA interactions at ER-endosome contacts result in VAPA-
mediated dissociation of RILP from p150Glued, with which VAPA associ-
ates in vitro, terminating its interaction with RILP [3]. RILP's interaction
with the HOPS complex is also disrupted by ORP1L–VAP interaction
[20], thusMCSs couple the regulation of bothminus-end-directed trans-
port with HOPS-mediated tethering and fusion (Fig. 2).
By terminating minus-ended transport, ORP1L–VAP interactions fa-
vour endosome transport towards the cell periphery. In a parallel, and
perhaps coordinated mechanism, protrudin interaction with PI3P and
Rab7 promotes the formation of contact sites that provide platforms
for Kinesin-1 loading onto late endosomes. Kinesin-1 interacts
with endosomal FYCO1 in a Rab7-dependent manner, promoting plus-end directed transport along microtubules (Fig. 2). As a consequence,
endosomes are translocated towards the periphery, where
synaptotagminVII-mediated fusion with the plasma membrane likely
provides necessary lipids for the protrusion and neurite outgrowth
that result [11].
Thus ER-endosome membrane contact sites coordinate the regula-
tion of endosome motility and positioning with endosome tethering
and fusion. Taken together with the demonstration that ER-endosome
contacts deﬁne sites of endosome ﬁssion, these data reveal the impor-
tance of ER-endosome contact sites in the regulation of the complex
functioning and maturation of the endocytic pathway. The role of cho-
lesterol in this process is interesting. Under conditions of high cholester-
ol in the endocytic pathway, for example in cells from NPC patients,
endocytic organelles accumulate in a perinuclear cluster [21].
Perinuclear clustering in cells lackingNPC1was corrected by expression
an ORP1L ΔORD mutant, lacking the oxysterol binding domain,
resulting in scattered endosomes as the mutant ORP1L promotes inter-
actionwithVAPA atMCSs, disrupting the RILP/p150Glued interaction and
thereby terminating minus-end directed transport [3]. Rab7 binding of
ORP1L and RILP thereby connects cholesterol sensing with endosomal
positioning, such that under conditions of high cholesterol, endosomes
are transported to theperinuclear region, presumably to facilitate fusion
with predominantly perinuclear lysosomes.
Conversely, consistent with a role for ORP1L in MCS formation, con-
tact sites were found to be increased under conditions of low cholester-
ol, with a consequent increase in a peripheral pool of endosomes [3].
Under these conditions, ORP1L adopts a conformation that interacts
with VAPA at MCSs. Coincident interaction of Rab7 with ORP1L and
RILP places RILP at the MCS, resulting in VAPA-mediated dissociation
of RILP and dynein, and a consequent loss of perinuclear endosome
transport. It is conceivable that endosome positioning might form part
of the cell's response to low exogenous cholesterol. When exogenous
cholesterol in the endocytic pathway is low, a feedback mechanism re-
sults in upregulation of the low density lipoprotein (LDL) receptor
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endosomes under these conditions might increase the efﬁciency of fu-
sion of clathrin-coated vesicles rich in upregulated LDLR with early
endosomes and sorting of the receptor back to the plasma membrane.
Alternatively their peripheral proximity might facilitate fusion of
recycling endosomes with the plasma membrane, possibly in a
VAMP8-dependent manner, as has been demonstrated in cytotoxic T
lymphocytes [23], or by synaptotagminVII-mediated endosome-
plasma membrane fusion [11] to return essential membrane proteins
and lipids to the plasma membrane for endocytosis of upregulated
LDL receptor.3.2. Regulation of growth factor receptors
Signalling from activated receptor tyrosine kinases (RTKs) is a key
regulator of critical cellular processes, including proliferation, differenti-
ation, survival and migration. As such, RTK activity must be tightly con-
trolled and endocytic trafﬁcking is central to the spatio-temporal
regulation of RTK activity. Signalling from the EGF receptor tyrosine ki-
nase, widely considered the prototypic RTK, occurs predominantly at
the plasma membrane [24], but can also continue from the limiting
membrane of endosomes where speciﬁc signalling pathways are acti-
vated [25].
Disregulated EGF receptor (EGFR) trafﬁc can result in aberrant activ-
ity of its RTK and is associated with increased mitogenic signalling and
tumourigenesis [26]. Thus regulation of RTK activity by endocytic traf-
ﬁcking has important consequences for cell fate. Activated EGFR is
targeted for lysosomal degradation by ubiquitination, which mediates
its interaction with components of the endosomal sorting complex re-
quired for transport (ESCRT) machinery and sorting onto endosomal
intraluminal vesicles (ILVs) [27]. The ESCRT-dependent formation of
ILVs within the lumen of the endosome, by a process of inward vesicu-
lation from the limiting membrane, generates endosomes known as
multivesicular bodies (MVBs). Sequestration of EGFR onto ILVs results
in attenuation of signal as the active RTK is physically separated from
its cytosolic targets. EGFR trafﬁcking and endosome biogenesis has
been extensively studied overmany decades, but only relatively recent-
ly did the role ofmembrane contact sites in the spatial regulation of RTK
activity become apparent.
The ﬁnding that an ER-localized phosphatase, protein tyrosine phos-
phatase 1B (PTP1B) interacts with endocytosed EGFR [28] sparked in-
terest in how these two proteins might come into contact. Some ten
years later, ER-endosome contact siteswere identiﬁed that provide plat-
forms for PTP1B-mediated effects at the endosome [2] (Fig. 2). PTP1B
was found to directly dephosphorylate both EGFR and granulocyte
colony stimulating factor receptors (G-CSFRs) at MCSs. G-CSFR on
early endosomes also interacts with the ER-localized antioxidant
peroxiredoxin Prdx4 and both G-CSFR and Prdx4 were found to be
hyperphosphorylated in the absence of PTP1B [29]. PTP1B-mediatedde-
phosphorylation of Prdx4 is predicted to increase its antioxidant activi-
ty, thereby maintaining PTP1B in an active state, with a resulting
reduction in G-CSFR tyrosine phosphorylation. In addition, PTP1B activ-
ity promotes both dephosphorylation of the ESCRT components Hrs [2]
and STAM [30] and, likely as a consequence of its ability tomodulate the
ESCRT machinery, the formation of ILVs. Thus PTP1B activity at ER-
endosome contact sites mediates RTK dephosphorylation and seques-
tration onto ILVs, with a consequent downregulation of RTK activity.
Paradoxically, while the predicted increase in ligand-stimulated phos-
phorylation of the EGFR was observed in PTP1B-null mouse ﬁbroblasts
[31], this was not accompanied by cell proliferation. This is possibly
due to the increased tyrosine phosphorylation of p62Dok observed in
PTP1B-deﬁcient cells, resulting in decreased Ras activity [32]. Moreover,
PTP1B activity was shown to promote ErbB2-dependent mammary tu-
morigenesis in vivo [33,34], possibly by dephosphorylation of an inhib-
itory tyrosine residue in c-Src, resulting in Src activation [35].4. Proposed functions for ER-endosome contact sites
4.1. Lipid transport
Lipid transport has been demonstrated across ER membrane con-
tact sites with other organelles, including OSBP-mediated ER to Golgi
sterol transfer [36]. That ORP1L, an OSBP homologue, is implicated in
ER-endosome contact site formation through interaction with VAP
on the ER, coupled with the regulation of ER-endosome contact site
extent by cholesterol sensing [3], has led to speculation that these
contact sites might also function in sterol transport [37,38]. The ma-
jority of the cell's exogenous cholesterol is derived from LDL
endocytosed via the LDL receptor, with the endocytic pathway
reported to contain a signiﬁcant amount of the total cellular choles-
terol [39]. Hydrolysis of endocytosed LDL releases free cholesterol in
endocytic organelles, which is transferred from the soluble NPC pro-
tein NPC2, in the lumen of the organelles, to membrane-bound NPC1
on the limiting membrane [40]. The ER-resident enzyme, Acyl-
CoA:cholesterol acyltransferase (ACAT), catalyses cholesterol esteri-
ﬁcation prior to storage in lipid droplets [41]. However, the exact
mechanism by which cholesterol reaches the ER from endocytic or-
ganelles remains unclear. The majority is believed to be transported
ﬁrst to the plasma membrane [42] and it is possible that MCSs might
play a role in directing positioning/ﬁssion of endocytic vesicles for
delivery to the plasma membrane.
The importance of NPC proteins for effective efﬂux of cholesterol
from the endocytic pathway is well documented, with loss of NPC1
or NPC2 resulting in the accumulation of intracellular free cholester-
ol and sphingolipids [43]. It is estimated that in addition to indirect
cholesterol transport via the plasma membrane, at least 30% of
LDL-cholesterol reaches the ER by a direct, non-vesicular route
[44,45]. NPC1 on late endosomes interacts with the ER-resident
oxysterol-binding protein-related protein 5 (ORP5), loss of which
also causes accumulation of LDL-cholesterol in the endocytic path-
way [46]. Thus the concept of direct transfer of LDL-derived choles-
terol between NPC1 and ORP5 at ER-endosome contact sites has
been mooted, but neither this, nor a direct role for NPC1 or ORP5 at
contact sites has yet been demonstrated.
ORP5 also interacts with the ESCRT protein Hrs and loss of Hrs,
like NPC1, also results in an accumulation of LDL-cholesterol in the
endocytic pathway [47]. It is unclear why LDL-cholesterol egress
should be disrupted by Hrs silencing. Since depletion of Tsg101, an-
other component of the ESCRT machinery required for cargo sorting
and endosome maturation, did not affect cholesterol transport [47],
it is unlikely to be due to the loss of ESCRT-mediated sorting/matura-
tion events. It is possible that Hrs is required for sorting sterol trans-
fer proteins to cholesterol-rich microdomains on the limiting
membrane, or that the stability of ORP5 interactions at the endosome
is reduced in the absence of Hrs, with a consequent loss of lipid trans-
fer. ORP5was recently found tomediate PI4P/phosphatidylserine ex-
change at ER-plasma membrane contact sites [48], which could
indicate a preference for phospholipid, rather than sterol binding. Al-
ternatively, could ORP5 function in sterol/phosphoinositide ex-
change at ER-endosome contacts, as has been demonstrated for
OSBP at ER-Golgi contact sites [36]?
How ORP1L might mediate the efﬂux of LDL-cholesterol from
endocytic organelles is hard to rationalize since ORP1L-VAP interac-
tions occur under conditions of low cholesterol in the endocytic
pathway. More likely, sterol binding by ORP1L contributes to sterol
sensing at the endosome, directing cholesterol-laden endosomes to-
wards the peri-nuclear compartment for lysosome fusion. Since
ORP1L can bind phosphoinositides through its PH domain, ORP1L
might, like OSBP36, also mediate sterol/phosphoinositide exchange
at ER-endosome contacts. Sterol transport across ER-endosome con-
tact sites will no doubt be the subject of intense scrutiny in future
studies.
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Ca2+ signals act as second messengers, mediating essential and
wide-ranging physiological processes and are therefore subject to
tight regulation. Cells achieve this by rapid spatiotemporal responses
that result in localized increases in Ca2+ concentrations by inﬂux of ex-
tracellular Ca2+ through Ca2+ channels in the plasma membrane and
release from intracellular Ca2+ stores. The ER is the cell's major store
of Ca2+, which can be released through the ER's calcium channels inosi-
tol triphosphate (IP3) receptors or ryanodine receptors [49]. With Ca2+
levels (approximately 0.5 mM), comparable with those found in the ER
[50], endocytic organelles also represent a major intracellular Ca2+
store and localized Ca2+ signals are important in endosomal fusion
events [51].
Functional coupling of these two major intracellular Ca2+ stores at
ER-lysosome contact sites has been proposed. Indeed direct mobiliza-
tion of lysosomal Ca2+ by osmotic permeabilisation is sufﬁcient to
evoke Ca2+ release from the ER [52]. Furthermore, this coupling was
also evident in the opposite direction. A study using sea urchin eggs,
found that Ca2+ release from the ER induced alkalinisation of endocytic
organelles, that accompanies Ca2+ release [53]. Computational model-
ling also supports the notion of bi-directional ampliﬁcation of ER and
endocytic organelle Ca2+ signals at MCSs [54,55]. It is known that
Ca2+ signals are required for normal endo-lysosomal fusion events
[51] and that MCSs also play a role in regulating endosomal positioning
and fusion events, as described above. Do Ca2+ signals recruit tethering
proteins to stabilize the contacts? ER-endosome contact sites were
found to be increased (likely reﬂectingmore stabilized contacts) follow-
ing stimulation with EGF [2], which induces an increase in cytosolic
Ca2+ [56]. The consequent increased PTP1B-EGFR interaction likely sta-
bilizes the MCS, but it is also possible that the Ca2+ spike following EGF
stimulation might serve to recruit a Ca2+-sensitive tether to promote
the formation of the ER-endosome contacts that provide sites of interac-
tion for PTP1B with endocytosed EGFR.
Ca2+ signals are important at ER contact sites with other organelles,
including the plasma membrane and mitochondria and at these con-
tacts there appears to be a close relationship between Ca2+ signals
and lipid transport. Data from NPC1 cells suggests that this might also
be true at ER contacts with endocytic organelles. The accumulation of
cholesterol in the endocytic pathway that characterizes NPC1 cells can
be reproduced by chelating endocytic organelle Ca2+ stores. Moreover,
Ca2+ levels in endocytic organelles are reduced inNPC1 cells and induc-
ing Ca2+ release by the ER corrects the cholesterol accumulation in
these cells [50]. It is possible that Ca2+ signals might be required to pro-
mote not only endo-lysosome fusion but also ER contact sites for the ef-
ﬂux of LDL-cholesterol from endocytic organelles. Could elevations in
Ca2+ at contact sites recruit tethering proteins required to stabilize
and extend the contact, providing a platform for sterol transfer from
the endosome? The sterol transfer proteins that compensate for the
lack of NPC1 on Ca2+ release from the ER remain elusive, but ORP1L is
a likely candidate, since expression of an adenoviral membrane protein,
RIDα, rescues the cholesterol accumulation phenotype in NPC1 cells in
an ORP1L-dependent manner, promoting lipid droplet formation [57].
How ORP1L transfers sterols under conditions of high LDL-cholesterol
is not yet fully understood, but ORP1L's interaction with the Oas1b-
containing complex in the ER [58] could be involved. The observation
that ORP5 on the ER is able to bind endosomal phospholipids through
its PH domain [59], raises the possibility that a sterol transfer protein
at the endosomemight not be required, but rather ORP5 might retrieve
sterols frommicrodomains on the limitingmembrane of the endosome.
The bidirectional ampliﬁcation of ER and lysosome Ca2+ signals is
widely believed to occur at contact sites between the two organelles.
It is likely that these localized elevations in Ca2+ signals promote endo-
some–lysosome fusion, consistent with the key role forMCSs in regulat-
ing the maturation and functioning of the endocytic pathway. Whether
or not Ca2+ also serves to promote the formation of contact sitesbetween the ER and endocytic organelles will surely become apparent
in the near future.
5. Conclusions and perspectives
Just as there are multiple populations of endocytic organelles
[13,60], it seems likely that multiple populations of ER contact sites
with endocytic organelles also exist, with organelle-speciﬁc tethering
complexes, that might for example, be recruited by Rab5 or Rab7,
markers of early or late endosomes respectively.
Several interactions between endosome and ER-localized proteins
have been reported, that may, as discussed, stabilize existing MCSs,
but no single regulator of ER-endosome contacts has been identiﬁed
to date. It is likely that, as is the case for ER-plasma membrane contact
sites [61], multiple interactions occur at the MCS, such that loss of
any individual component has little effect. Such a robust system of
interorganellar communication is likely to reﬂect the physiological im-
portance of the interactions and exchange that occur at contact sites. In-
deed MCS disruption has been implicated in a number of diseases [37].
The yeast protein Mdm1 was recently identiﬁed as a tethering compo-
nent for ER-vacuole contact sites [62]. The role of the mammalian
Mdm1 homologue, sorting nexin 14 (SNX14), in tethering ER contact
sites with endocytic organelles has not yet been established. However,
Mdm1 truncations analogouswith SNX14mutations that are associated
with a neurological disorder characterized by intellectual disability and
cerebella atrophy, failed to tether ER-vacuole contact sites in yeast,
strongly implicating ER contact sites with endocytic organelles in the
pathogenesis of the disease associated with SNX14 mutations.
While our understanding of the biology of membrane contact sites
between the ER and endocytic organelles has progressed enormously
in recent years, much remains to be elucidated. Recent advances in
super-resolution and 3Dmicroscopy techniques should further acceler-
ate progress in this rapidly developing ﬁeld.
Conﬂict of interest
I wish to conﬁrm that there are no known conﬂicts of interest asso-
ciated with this publication and there has been no signiﬁcant ﬁnancial
support for this work that could have inﬂuenced its outcome.
Acknowledgements
This work was supported by grants from the Medical Research
Council (award number 166002) and the Wellcome Trust (093445).
References
[1] X. Pan, et al., Nucleus–vacuole junctions in Saccharomyces cerevisiae are formed
through the direct interaction of Vac8p with Nvj1p, Mol. Biol. Cell 11 (2000)
2445–2457.
[2] E.R. Eden, I.J. White, A. Tsapara, C.E. Futter, Membrane contacts between endosomes
and ER provide sites for PTP1B-epidermal growth factor receptor interaction, Nat.
Cell Biol. 12 (2010) 267–272.
[3] N. Rocha, et al., Cholesterol sensor ORP1L contacts the ER protein VAP to control
Rab7-RILP-p150 Glued and late endosome positioning, J. Cell Biol. 185 (2009)
1209–1225.
[4] M.J. Phillips, G.K. Voeltz, Structure and function of ER membrane contact sites with
other organelles, Nat. Rev. Mol. Cell Biol. (2015).
[5] A. Gonzalez Montoro, C. Ungermann, StARTing to understand membrane contact
sites, Trends Cell Biol. 25 (2015) 497–498.
[6] T. Burgoyne, S. Patel, E.R. Eden, Calcium signaling at ER membrane contact sites,
Biochim. Biophys. Acta 1853 (2015) 2012–2017.
[7] R. Stoica, et al., ER-mitochondria associations are regulated by the VAPB-PTPIP51 in-
teraction and are disrupted by ALS/FTD-associated TDP-43, Nat. Commun. 5 (2014)
3996.
[8] D. Peretti, N. Dahan, E. Shimoni, K. Hirschberg, S. Lev, Coordinated lipid transfer be-
tween the endoplasmic reticulum and the Golgi complex requires the VAP proteins
and is essential for Golgi-mediated transport, Mol. Biol. Cell 19 (2008) 3871–3884.
[9] C.J. Stefan, et al., Osh proteins regulate phosphoinositide metabolism at ER-plasma
membrane contact sites, Cell 144 (2011) 389–401.
[10] F. Alpy, et al., STARD3 or STARD3NL and VAP form a novel molecular tether between
late endosomes and the ER, J. Cell Sci. 126 (2013) 5500–5512.
879E.R. Eden / Biochimica et Biophysica Acta 1861 (2016) 874–879[11] C. Raiborg, et al., Repeated ER-endosome contacts promote endosome translocation
and neurite outgrowth, Nature 520 (2015) 234–238.
[12] T. Vihervaara, et al., Sterol binding by OSBP-related protein 1L regulates late endo-
some motility and function, Cell. Mol. Life Sci. 68 (2011) 537–551.
[13] R. van der Kant, I. Zondervan, L. Janssen, J. Neefjes, Cholesterol-binding molecules
MLN64 and ORP1L mark distinct late endosomes with transporters ABCA3 and
NPC1, J. Lipid Res. 54 (2013) 2153–2165.
[14] M. Johansson, M. Lehto, K. Tanhuanpaa, T.L. Cover, V.M. Olkkonen, The oxysterol-
binding protein homologue ORP1L interacts with Rab7 and alters functional proper-
ties of late endocytic compartments, Mol. Biol. Cell 16 (2005) 5480–5492.
[15] D. Poteryaev, S. Datta, K. Ackema, M. Zerial, A. Spang, Identiﬁcation of the switch in
early-to-late endosome transition, Cell 141 (2010) 497–508.
[16] J. Huotari, A. Helenius, Endosome maturation, EMBO J. 30 (2011) 3481–3500.
[17] A.A. Rowland, P.J. Chitwood, M.J. Phillips, G.K. Voeltz, ER contact sites deﬁne the
position and timing of endosome ﬁssion, Cell 159 (2014) 1027–1041.
[18] J.S. Bonifacino, J.H. Hurley, Retromer, Curr. Opin. Cell Biol. 20 (2008) 427–436.
[19] E. Nielsen, F. Severin, J.M. Backer, A.A. Hyman, M. Zerial, Rab5 regulates motility of
early endosomes on microtubules, Nat. Cell Biol. 1 (1999) 376–382.
[20] R. van der Kant, et al., Late endosomal transport and tethering are coupled processes
controlled by RILP and the cholesterol sensor ORP1L, J. Cell Sci. 126 (2013)
3462–3474.
[21] D.C. Ko, M.D. Gordon, J.Y. Jin, M.P. Scott, Dynamic movements of organelles contain-
ing Niemann-Pick C1 protein: NPC1 involvement in late endocytic events, Mol. Biol.
Cell 12 (2001) 601–614.
[22] M.S. Brown, J.L. Goldstein, Regulation of the activity of the low density lipoprotein
receptor in human ﬁbroblasts, Cell 6 (1975) 307–316.
[23] M.R. Marshall, et al., VAMP8-dependent fusion of recycling endosomes with the
plasma membrane facilitates T lymphocyte cytotoxicity, J. Cell Biol. 210 (2015)
135–151.
[24] L.P. Sousa, et al., Suppression of EGFR endocytosis by dynamin depletion reveals
that EGFR signaling occurs primarily at the plasma membrane, Proc. Natl. Acad.
Sci. U. S. A. 109 (2012) 4419–4424.
[25] A.V. Vieira, C. Lamaze, S.L. Schmid, Control of EGF receptor signaling by clathrin-
mediated endocytosis, Science 274 (1996) 2086–2089.
[26] A. Tomas, C.E. Futter, E.R. Eden, EGF receptor trafﬁcking: consequences for signaling
and cancer, Trends Cell Biol. 24 (2014) 26–34.
[27] R.L. Williams, S. Urbe, The emerging shape of the ESCRT machinery, Nat. Rev. Mol.
Cell Biol. 8 (2007) 355–368.
[28] F.G. Haj, P.J. Verveer, A. Squire, B.G. Neel, P.I. Bastiaens, Imaging sites of receptor de-
phosphorylation by PTP1B on the surface of the endoplasmic reticulum, Science 295
(2002) 1708–1711.
[29] K. Palande, et al., Peroxiredoxin-controlled G-CSF signalling at the endoplasmic
reticulum-early endosome interface, J. Cell Sci. 124 (2011) 3695–3705.
[30] M. Stuible, et al., PTP1B targets the endosomal sorting machinery: dephosphoryla-
tion of regulatory sites on the endosomal sorting complex required for transport
component STAM2, J. Biol. Chem. 285 (2010) 23899–23907.
[31] F.G. Haj, B. Markova, L.D. Klaman, F.D. Bohmer, B.G. Neel, Regulation of receptor
tyrosine kinase signaling by protein tyrosine phosphatase-1B, J. Biol. Chem. 278
(2003) 739–744.
[32] N. Dube, A. Cheng, M.L. Tremblay, The role of protein tyrosine phosphatase 1B in Ras
signaling, Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 1834–1839.
[33] S.G. Julien, et al., Protein tyrosine phosphatase 1B deﬁciency or inhibition delays
ErbB2-induced mammary tumorigenesis and protects from lung metastasis, Nat.
Genet. 39 (2007) 338–346.
[34] M. Bentires-Alj, B.G. Neel, Protein-tyrosine phosphatase 1B is required for HER2/
Neu-induced breast cancer, Cancer Res. 67 (2007) 2420–2424.
[35] S. Zhu, J.D. Bjorge, D.J. Fujita, PTP1B contributes to the oncogenic properties of colon
cancer cells through Src activation, Cancer Res. 67 (2007) 10129–10137.
[36] B. Mesmin, et al., A four-step cycle driven by PI(4)P hydrolysis directs sterol/PI(4)P
exchange by the ER-Golgi tether OSBP, Cell 155 (2013) 830–843.
[37] C. Raiborg, E.M. Wenzel, H. Stenmark, ER-endosome contact sites: molecular
compositions and functions, EMBO J. (2015).
[38] R. van der Kant, J. Neefjes, Small regulators, major consequences — Ca2+ and
cholesterol at the endosome-ER interface, J. Cell Sci. 127 (2014) 929–938.[39] W. Mobius, et al., Recycling compartments and the internal vesicles of
multivesicular bodies harbor most of the cholesterol found in the endocytic path-
way, Trafﬁc 4 (2003) 222–231.
[40] H.J. Kwon, et al., Structure of N-terminal domain of NPC1 reveals distinct
subdomains for binding and transfer of cholesterol, Cell 137 (2009) 1213–1224.
[41] C.C. Chang, H.Y. Huh, K.M. Cadigan, T.Y. Chang, Molecular cloning and functional ex-
pression of human acyl-coenzyme A:cholesterol acyltransferase cDNA in mutant
Chinese hamster ovary cells, J. Biol. Chem. 268 (1993) 20747–20755.
[42] A. Das, M.S. Brown, D.D. Anderson, J.L. Goldstein, A. Radhakrishnan, Three pools of
plasma membrane cholesterol and their relation to cholesterol homeostasis, eLife
3 (2014).
[43] E. Lloyd-Evans, F.M. Platt, Lipids on trial: the search for the offending metabolite in
Niemann-Pick type C disease, Trafﬁc 11 (2010) 419–428.
[44] E.B. Neufeld, et al., Intracellular trafﬁcking of cholesterol monitored with a cyclodex-
trin, J. Biol. Chem. 271 (1996) 21604–21613.
[45] K.W. Underwood, N.L. Jacobs, A. Howley, L. Liscum, Evidence for a cholesterol trans-
port pathway from lysosomes to endoplasmic reticulum that is independent of the
plasma membrane, J. Biol. Chem. 273 (1998) 4266–4274.
[46] X. Du, et al., A role for oxysterol-binding protein-related protein 5 in endosomal
cholesterol trafﬁcking, J. Cell Biol. 192 (2011) 121–135.
[47] X. Du, A.S. Kazim, A.J. Brown, H. Yang, An essential role of Hrs/Vps27 in endosomal
cholesterol trafﬁcking, Cell Rep. 1 (2012) 29–35.
[48] J. Chung, et al., INTRACELLULARTRANSPORT. PI4P/phosphatidylserine countertransport
at ORP5- and ORP8-mediated ER-plasma membrane contacts, Science 349 (2015)
428–432.
[49] M.J. Berridge, M.D. Bootman, H.L. Roderick, Calcium signalling: dynamics, homeosta-
sis and remodelling, Nat. Rev. Mol. Cell Biol. 4 (2003) 517–529.
[50] E. Lloyd-Evans, et al., Niemann-Pick disease type C1 is a sphingosine storage disease
that causes deregulation of lysosomal calcium, Nat. Med. 14 (2008) 1247–1255.
[51] P.R. Pryor, B.M. Mullock, N.A. Bright, S.R. Gray, J.P. Luzio, The role of intraorganellar
Ca(2+) in late endosome-lysosome heterotypic fusion and in the reformation of
lysosomes from hybrid organelles, J. Cell Biol. 149 (2000) 1053–1062.
[52] B.S. Kilpatrick, E.R. Eden, A.H. Schapira, C.E. Futter, S. Patel, Direct mobilisation of
lysosomal Ca2+ triggers complex Ca2+ signals, J. Cell Sci. 126 (2013) 60–66.
[53] A.J. Morgan, et al., Bidirectional Ca(2)(+) signaling occurs between the endoplasmic
reticulum and acidic organelles, J. Cell Biol. 200 (2013) 789–805.
[54] N. Fameli, O.A. Ogunbayo, C. van Breemen, A.M. Evans, Cytoplasmic nanojunctions
between lysosomes and sarcoplasmic reticulum are required for speciﬁc calcium
signaling, F1000Research 3 (2014) 93.
[55] C.J. Penny, B.S. Kilpatrick, J.M. Han, J. Sneyd, S. Patel, A computational model of
lysosome-ER Ca2+ microdomains, J. Cell Sci. 127 (2014) 2934–2943.
[56] A. Gilligan, M. Prentki, C. Glennon, B.B. Knowles, Epidermal growth factor-induced
increases in inositol trisphosphates, inositol tetrakisphosphates, and cytosolic
Ca2+ in a human hepatocellular carcinoma-derived cell line, FEBS Lett. 233
(1988) 41–46.
[57] N.L. Cianciola, D.J. Greene, R.E. Morton, C.R. Carlin, Adenovirus RIDalpha uncovers a
novel pathway requiring ORP1L for lipid droplet formation independent of NPC1,
Mol. Biol. Cell 24 (2013) 3309–3325.
[58] S.C. Courtney, et al., Identiﬁcation of novel host cell binding partners of Oas1b, the
protein conferring resistance to ﬂavivirus-induced disease in mice, J. Virol. 86
(2012) 7953–7963.
[59] X. Du, H. Yang, Endosomal cholesterol trafﬁcking: protein factors at a glance, Acta
Biochim. Biophys. Sin. 45 (2013) 11–17.
[60] I.J. White, L.M. Bailey, M.R. Aghakhani, S.E. Moss, C.E. Futter, EGF stimulates annexin
1-dependent inward vesiculation in a multivesicular endosome subpopulation,
EMBO J. 25 (2006) 1–12.
[61] A.G. Manford, C.J. Stefan, H.L. Yuan, J.A. Macgurn, S.D. Emr, ER-to-plasma membrane
tethering proteins regulate cell signaling and ER morphology, Dev. Cell 23 (2012)
1129–1140.
[62] W.M. Henne, et al., Mdm1/Snx13 is a novel ER-endolysosomal interorganelle tether-
ing protein, J. Cell Biol. 210 (2015) 541–551.
